Bruce Carlson[email protected]Business InsightsRomanian IVD market worth watching, rose to $464M in 2022The Eastern European country's IVD market will grow 25% faster than that of the United States, according to Kalorama Information in its latest 30-Country IVD Market Atlas.May 31, 2023Business InsightsU.K. IVD market grows to $4.6 billion; Brexit not a factorThe U.K. market is expected to grow just under 3% per year for the next five years, the report said, faster than Italy, France, or the Netherlands, and at about the same rate as Germany.May 4, 2023Business InsightsDeclining COVID-19 test market may still reach $25M in 2023: ReportDespite a decline in sales, COVID-19 is expected to represent one of the larger single-disease categories in IVD testing, according to Kalorama. Rapid testing, mostly antigen-based, will hold up the market while growth drops in lab-based PCR testing.April 28, 2023Business InsightsPoint-of-care IVD sales rose to $45 billion in 2022Numerous trends will combine to enable a growing market. According to the Kalorama report, growth of 3.3% per year is expected over the forecast period from 2022 to 2027.April 19, 2023Business InsightsBrazilian IVD market rises to $1.7BThe demand for clinical testing equipment in Brazil is partly driven by an aging population, Kalorama noted. People 65 and over are expected to account for 14.1% of the total population by 2032.April 18, 2023Business InsightsSwedish IVD market estimated at $804 million in 2022: Kalorama InformationCritical care point-of-care tests, used for assessment of emergency room (ER) and intensive care unit (ICU) patients in hospitals or ambulatory settings, are expected to grow about three times faster in Sweden than in the U.S. over the next five years.March 31, 2023Business InsightsU.S. IVD market reaches $53 billionAccording to Kalorama Information, the U.S. IVD market is projected to grow at a 2.4% average annual rate through 2027.March 22, 2023Business InsightsIVD physician office market was $8.3 billion in 2022: KaloramaAn increase in the number of diseases for which physician offices are often the first to test is influencing physician office lab IVD revenue growth.January 23, 2023Liquid Biopsy$1.3 billion liquid biopsy market represents the present and future of clinical oncology: KaloramaThe liquid biopsy market can be segmented by the type of analyte detected and analyzed. There are four main categories: circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes and other analytes, and multiple analytes.January 19, 2023Business InsightsHighly competitive molecular diagnostics market reaches $21B: KaloramaThe market largely consists of COVID-19 sales, but future growth in the market will be fueled by other applications, according to Kalorama Information.November 8, 2022Page 1 of 7Next PageTop StoriesValidationImmunovia announces positive results for next-gen pancreatic cancer testDiagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.CollaborationVertex to pay $25M upfront to scale cell manufacturing technologyLawsuitU.K. Patents Court rules Bio-Techne patents invalid in infringement lawsuitPoint-of-Care TestingScout secures CARB-X grant to advance diagnostic test developmentSponsor ContentVisit our Molecular Diagnostics Community
